netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.08  Expand sub section  Sunscreens and camouflagers
Aminolevulinic acid
(Actinic keratosis)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Secondary care notes

  • RFL approvals
    • First line treatment of actinic keratosis and basal cell carcinoma
    • Ameluz ®
  • WH approvals
    • First line treatment of actinic keratosis and basal cell carcinoma
    • Ameluz ®
 
   
13.08.01  Expand sub section  Sunscreen preparations
Sunscreen (Anthelios XL 50+ comfort cream)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Approved for ACBS indication 'photosensitive dermatoses and photodermatoses' (JFC April 2016). 

Anthelios XL SPF 50+ Comfort Cream presents in a small pack size and therefore may be most useful for frequent application to face and the back of hands (areas that are most exposed to the sun) whilst Uvistat may be beneficial for application to larger areas.

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to dermatology
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • See indication above 
 
   
Sunscreen (Uvistat)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Approved for ACBS indications = photosensitive dermatoses and photodermatoses (JFC April 2016). 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Only Uvistat Cream SPF 30 is kept
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Cream 100 UVB-SPF 50 only
 
   
13.08.01  Expand sub section  Photodamage
Diclofenac 3% gel (Solaraze)
(Actinic keratosis)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Restricted to Dermatologists
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Fluorouracil 5% cream (Efudix)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Methyl-5-Aminolevulinate (Metvix)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Secondary care notes

  • RFL approvals
    • First line treatment for Bowen's disease and second line treatment for AK and BCC
  • WH approvals
    • First line treatment for Bowen's disease and second line treatment for AK and BCC
 
   
13.08.02  Expand sub section  Camouflagers
 ....
 Non Formulary Items
Camouflagers  (Covermark)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Camouflagers  (Dermablend®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Camouflagers  (Dermacolor)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Camouflagers  (Keromask)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Camouflagers  (Veil)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Dundee reflective sun creams  (Dundee Block)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fluorouracil 0.5% + Salicylic acid 10% solution  (Actikerall)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ingenol mebutate 150/g gel  (Picato)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for actinic keratoses (March 2013)

 
Sunscreen  (Delph®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (E45 Sun)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (Roc)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (SpectraBan)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (Sunsense Ultra)

View adult BNF View SPC online View childrens BNF
Non Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary